Vav1 Promotes B-Cell Lymphoma Development
Batel Shalom1, Marganit Farago1, Yaser Salaymeh1
1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hadassah Medical School, Hebrew University, P.O. Box 12272, Jerusalem 91120, Israel.
Cells
|March 25, 2022
Summary
Overexpression of Vav1 in non-hematopoietic tissues surprisingly induced B-cell lymphomas in mice. This suggests a novel cross-talk mechanism involving Vav1, CSF-1, and CSF-1R in tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Vav1 is a GDP/GTP nucleotide exchange factor (GEF) crucial in the hematopoietic system.
- Vav1 mutations and overexpression are linked to various cancers.
- The role of Vav1 in non-hematopoietic tissues regarding cancer development is not fully understood.
Purpose of the Study:
- To investigate if Vav1 overexpression in epithelial tissues can promote malignant lesion development.
- To elucidate the signaling pathways and cellular interactions involved in Vav1-induced tumorigenesis.
Main Methods:
- Generation of transgenic mice (Rosa Vav1) with ubiquitous Vav1 expression using the ROSA26 promoter.
- Analysis of Vav1 expression in various epithelial tissues.
- Assessment of B-cell lymphoma development.
- Evaluation of signaling pathway activation (ERK phosphorylation) and growth factor involvement (CSF-1/CSF-1R).
Main Results:
- Vav1 was expressed in epithelial tissues of pancreas, liver, and lung in Rosa Vav1 mice.
- No carcinomas developed, but B-cell lymphomas emerged.
- ERK phosphorylation increased in lymphomas, while Rac1-GTP levels remained unchanged.
- High expression of CSF-1 in epithelial cells and CSF-1R in lymphomas was observed.
Conclusions:
- Vav1 overexpression in epithelial tissues can lead to B-cell lymphoma development, not carcinomas.
- A novel paracrine cross-talk mechanism between Vav1-expressing epithelial cells (secreting CSF-1) and lymphocytes (expressing CSF-1R) is proposed.
- This cross-talk contributes to tumor propagation and lymphoma generation.
Related Concept Videos
B Cell Activation and Differentiation
7.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
7.8K
Mechanisms of Retrovirus-induced Cancers
5.4K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K
Lymphoid Cells and Tissues
1.8K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.8K
Rous Sarcoma Virus (RSV) and Cancer
5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.5K
Primary Lymphoid Organs
8.4K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
8.4K
T Cell Activation and Clonal Selection
6.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
6.7K


